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Abstract
Allergic reactions to chemicals, food products or even insect bites are
encountered all over the world with a variety of manifestations. Symptoms range
from the development of a minor rash to life threatening anaphylactic reactions.
Sometimes, acute coronary syndrome (ACS) can be registered in such patients,
which may have a serious impact on the course and management of the allergic
reaction. Mushroom poisoning constitutes the main portion of plant toxicities in
Spain. Depending on the type of mushroom, the adverse effects range from mild
gastrointestinal (GI) symptoms to major cytotoxic effects resulting in organ failure
and death. Coprinopsis atramentaria poisoning is rare but with serious
consequences. We report a case of a 27 year old patient with a previous history of
mild persistent asthma, nasal polyps and aspirin allergy that arrived to the
Emergency Department with dizziness and temor after consuming beer at a party.
On arrival to the hospital, the patient suddenly collapsed, with an
electrocardiogram (ECG) showing ST elevation in the inferior leads and 3rd degree
atrioventricular (AV) block accompanied by urticarial-like lesions. After
administration of treatment, the patient and ECG abnormalities improved. A
detailed medical history showed that the patient had eaten scrambled mushrooms
and beer. Expert analysis demonstrated that the combined consumption of
Coprinopsis atramentaria and alcoholic beverages produced a disulfiram-like
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reaction (Coprinic syndrome) and type I Kounis syndrome. No case like this has
been previously reported.
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Case report
A 27-year-old man, with no cardiovascular risk factors and a history of mild
persistent asthma, nasal polyps and aspirin allergy, was transferred with dizziness
and vomiting to the hospital after consumption of beer at a party. Approximately 5
minutes after arrival to the hospital, he complained of chest pain, accompanied by
nausea and diaphoresis. Urticarial skin lesions appeared, scattered on the trunk
and extremities, and syncope ensued with loss of consciousness. Physical
examination demonstrated a heart rate of 30 bpm and severe hypotension (60/40
mmHg). An electrocardiogram (ECG) revealed ST elevation of 2 mm in leads II, III
and aVF, with a specular reflection on leads I and aVL, V1-V4 and 3rd degree
atrioventricular (AV) block (figure 1). Following administration of oxygen,
adrenaline, corticosteroids, antihistamines, clopidrogel and low molecular weight
heparin the patient became hemodynamically stable, The patient’s blood pressure
by this time was 123/76 mmHg. The rash disappeared completely over the next 2-3
h and the electrocardiographic findings returned to normal, with an ECG showing
normal sinus rhythm (figure 2), with ST segment correction. With the diagnosis of
Kounis syndrome the patient was admitted to the intensive care unit (ICU).
Echocardiogram showed hypokinesia of the mid-inferior left ventricle (LV). Blood
analysis revealed a total Creatine Kinase (CK) fraction of 1,790 U/L (normal: 25–
150), CK-MB fraction of 256 U/L (normal: 5–20), and troponin I value of 3.17 ng/mL
(normal: 0.030). Additional blood tests revealed tryptase values of 15.1 g/L. Heart
catheterization revealed the presence of angiographically normal coronary
arteries; 72 hours later serum tryptase values had returned to normal (3.23 g/L). A
detailed medical history showed that the patient had consumed scrambled
mushrooms and 2 beers at a dinner party; the mushrooms had been obtained
from a private garden, a sample was brought (figure 3) and identified by an expert
as Coprinopsis atramentaria. Five days after discharge, repeat echocardiogram
did not reveal any contractility abnormalities or valvular disease, and the ejection
fraction was normal. The temporal association of development of chest pain, ECG
changes, positive Troponin, inferior wall hypokinesia with anaphylactic
manifestations due to ingestion of mushrooms and then everything normalizing
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together in a few days strongly suggested that the cardiac event was related to the
allergic reaction. The patient also had symptoms and signs suggesting coprinic
syndrome secondary to Coprinopsis atramentaria, including facial erythrosis,
hypotension and trembling of the extremities. During allergy screening tests, it
was found that the patient was allergic to contact, drugs and food. The patient was
advised to avoid these allergens and use topical steroids, bilastin and montelukast.
Up until the current date, the patient has been doing well.
Discussion
Mushroom poisoning occurs frequently, but serious toxicity is uncommon. There
are 12 groups of identified mushroom toxins with 14 described clinical syndromes.
Defining which clinical syndrome predominates, initiating general supportive
care, and administering any specific treatments for that syndrome are the key
steps in the recognition and management of mushroom poisoning. (1,2) The toxin
coprine, when ingested before consumption of ethanol, results in a disulfiram-
like reaction. (1,3,4) Coprinopsis atramentaria, the “inky cap” mushroom, and
related species are most commonly associated with this syndrome. Previously
known as Coprinopsis atramentaria, it is the second best known ink cap and
previous member of the genus Coprinus after C. comatus. It is a widespread and
common fungus found throughout the northern hemisphere, arises in small
clumps from spring until early winter, commonly in urban and disturbed habitats
such as vacant lots and lawns, as well as grassy areas. The grey-brown cap is
initially bell-shaped before opening, after which, it flattens and disintegrates.
Coprine is heat-stable, so boiling or cooking the mushrooms does not prevent
toxicity. The metabolites of coprine, including 1-aminocyclopropanol and
cyclopropanone hydrate, irreversibly inhibit aldehyde dehydrogenase. (1,3,4) This
effect causes a marked elevation of blood aldehyde when ethanol is ingested
several hours to seven days after Coprinus mushroom consumption. However, if
alcohol is ingested at the same time as coprine-containing mushrooms, toxicity
often does not occur or is lessened because the metabolism of coprine is slower
than the normal hepatic elimination of ethanol. Clinical effects usually occur
within two hours of ethanol ingestion and include; headache, flushing of the face,
neck, and trunk, Nausea and vomiting, tachycardia, palpitations, chest pain,
dyspnea, marked apprehensiveness, rarely, hypotension, cardiac dysrhythmia,
confusion, and/or coma. Treatment of toxicity is supportive. Clinical findings are
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self-limited and typically resolve after three to six hours, although, they can rarely
persist as long as 24 hours. (3) Alcohol intolerance can also be precipitated by
mushroom species other than Coprinopsis atramentaria (eg, Lepiota aspera).
Although the pathophysiology of intolerance and toxicity is not well characterized,
the treatment is the same. (5)
The first report of myocardial infarction during an allergic reaction (to penicillin)
was published in 1950. (6) Kounis and Zarvas (7) introduced the concept and
nomenclature of the “syndrome of allergic angina” in 1991, and 5 years later (8)
they described the “syndrome of allergic myocardial infarction”. Today, Kounis
syndrome is a recognized cause of acute coronary syndrome and many etiologies
have been reported, (9,10) including drugs (antibiotics, analgesics, antineoplastics,
contrast media, corticosteroids, intravenous anesthetics, non-steroidal anti-
inflammatory drugs, skin disinfectants, thrombolytics, anticoagulants), various
conditions (angioedema, bronchial asthma, rhinitis, nasal polyp, urticaria, food
allergy, exercise-induced allergy, mastocytosis, serum sickness), environmental
exposure (stings of ants, bees, wasps and jellyfish, grass cuttings, millet allergy,
poisoning, latex contact, eating shellfish, viper venom poisoning, anisakis). Until
our report, no case had been reported related to mushroom poisoning. Many
experts believe that Kounis Syndrome is not a rare disease but a ‘rarely diagnosed’
disease.
Three variants of Kounis syndrome have been described so far. (11) The type I
variant (coronary spasm), which might represent a manifestation of endothelial
dysfunction or microvascular angina, includes patients with normal coronary
arteries without predisposing factors for coronary artery disease in whom the
acute release of inflammatory mediators can induce either coronary artery spasm
without increase of cardiac enzymes and troponins or coronary artery spasm
progressing to acute myocardial infarction with raised cardiac enzymes and
troponins. The type II variant (coronary thrombosis) includes patients with culprit
but quiescent pre-existing atheromatous disease in whom the acute release of
inflammatory mediators can induce either coronary artery spasm with normal
cardiac enzymes and troponins, plaque erosion or rupture, manifesting as acute
myocardial infarction. Recently a 3rd variant has been suggested including
patients with coronary artery stent thrombosis in whom eosinophils and mast
cells were isolated in the thrombus. (12) The diagnosis is primarily clinical and is
based on symptoms and signs suggestive of an acute allergic reaction and acute
coronary event coincident in time. The patient can present as an acute coronary
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syndrome manifesting as anginal chest pain, nausea and diaphoresis and
simultaneously typical symptoms of an anaphylactic reactions in the context of
contact with known allergens including hypotension, skin symptoms (rash,
urticaria, angioedema), breathing (dyspnoea, wheezing, hoarseness, stridor)
and/or gastrointestinal (abdominal pain, nausea, vomiting).
The treatment of these allergic angina pectoris syndromes involves managingboth
the acute coronary syndrome and the allergic syndrome simultaneously.
Cevik et al. suggested treating the anaphylactic or anaphylactoid reaction with
epinephrine, corticosteroids, antihistamines (both H1- and H2-blockers), fluid
resuscitation, and oxygen. (13) During the allergic reaction, if the patient develops
chest pain and allergic angina pectoris or if myocardial infarction is suspected,
emergent catheterization should be considered for both diagnostic and
therapeutic reasons. Without angiographic evidence or a prior history of an
allergic angina-type syndrome, it is difficult to start treating someone for this
disease in the emergency department. Once vasospasm is diagnosed through
cardiac catheterization, vasodilator drugs such as intracoronary nitrates and
calcium channel blockers are recommended. Revascularization or
antithrombotics may be appropriate in type II variants. If the culprit allergen is
known, the implicated causal factor should be strictly avoided. Along with
epinephrine, long-term use of mast cell stabilizers, such as cromolyn sodium or
nedocromil sodium, and antihistamines may be considered.
The patient had a previous recognized history of mild persistent asthma, nasal
polyps and aspirin allergy consistent with the Samter’s triad (asthma, aspirin
sensitivity, and nasal polyps). The term Samter’s triad has become popular.
Several cases of Kounis syndrome in patients with Samter’s triad have been
reported; whether there is a direct relationship in the current case should be
further investigated. In this patient there is a rare combination of mushroom
poisoning syndrome (coprinic syndrome) and Kounis syndrome. When there is a
young individual with no predisposing factors for atherosclerosis, and an
apparent coronary lesion, with or without ECG and biochemical markers of
infarction, the possibility of Kounis syndrome should always be kept in mind.
Figure 1. Electrocardiogram on arrival showing ST elevation of 2 mm in leads II, III
and aVF, with a specular reflection on leads I and aVL, V1-V4 and 3rd degree
atrioventricular (AV) block.
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Figure 2. Electrocardiogram showing normal sinus rhythm with ST segment
correction after administration of treatment.
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Figure 3. Coprinopsis atramentaria.
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